Back
Citius Pharmaceuticals Vs. Lemonade Industry Stock Comparison
Sell
46
CTXR
Citius Pharmaceuticals
Last Price:
0.34
Seasonality Move:
21.66%
Buy
100
LMND
Lemonade
Last Price:
31.89
Seasonality Move:
29.67%
Sell
46
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy, Sell or Hold?
- The current Citius Pharmaceuticals [CTXR] share price is $0.39. The Score for CTXR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- CTXR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
100
Lemonade (LMND)
is a Buy
Is Lemonade a Buy, Sell or Hold?
- The current Lemonade [LMND] share price is $31.99. The Score for LMND is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
- LMND is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
CTXR Stock Price Chart
What is Citius Pharmaceuticals's stock price today?
-
The Citius Pharmaceuticals share price today is $0.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing selling pressure, which indicates risk of future bearish movement.
CTXR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 46.64 | Sell |
Chaikin Money Flow: | -1938218 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.35 - 0.41) | Buy |
Bollinger Bands (100): | (0.4 - 0.76) | Sell |
LMND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.67 | Buy |
Relative Strength Index (14 RSI): | 73.76 | Buy |
Chaikin Money Flow: | -1582114 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.77 - 27.51) | Buy |
Bollinger Bands (100): | (15.32 - 22.8) | Buy |
CTXR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.39 | Sell |
20-day SMA: | 0.38 | Buy |
50-day SMA: | 0.44 | Sell |
200-day SMA: | 0.65 | Sell |
8-day EMA: | 0.41 | Sell |
20-day EMA: | 0.4 | Sell |
50-day EMA: | 0.45 | Sell |
200-day EMA: | 0.63 | Sell |
LMND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.02 | Buy |
20-day SMA: | 23.33 | Buy |
50-day SMA: | 19.8 | Buy |
200-day SMA: | 17.91 | Buy |
8-day EMA: | 29.24 | Buy |
20-day EMA: | 24.96 | Buy |
50-day EMA: | 21.32 | Buy |
200-day EMA: | 18.44 | Buy |
Citius Pharmaceuticals Earnings Growth & CTXR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.
Lemonade Earnings Growth & LMND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and an increase next year of $0.41 per share.
Citius Pharmaceuticals Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lemonade Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |